Potez, Marine; Rome, Claire; Lemasson, Benjamin; Heemeryck, Pierre; Laissue, Jean Albert; Stupar, Vasile; Mathieu, Hervé; Collomb, Nora; Barbier, Emmanuel; Djonov, Valentin; Bouchet, Audrey (2024). Microbeam Radiation Therapy opens a several days vessel permeability window for small molecules in brain tumor vessels. International journal of radiation oncology, biology, physics, 119(5), pp. 1506-1516. Elsevier 10.1016/j.ijrobp.2024.02.007
Text
1-s2.0-S0360301624003158-main.pdf - Accepted Version Restricted to registered users only until 19 February 2025. Available under License Publisher holds Copyright. Download (1MB) |
PURPOSE
Synchrotron microbeam radiation therapy (MRT), based on an inhomogeneous geometric and microscopic irradiation pattern of the tissues with high dose and high dose rate X-rays, enhances the permeability of brain tumor vessels. This study attempts to determine time and size range of the permeability window induced by MRT in the blood brain (tumor) barrier.
METHODS AND MATERIALS
Rats-bearing 9L gliomas were exposed to MRT, either unidirectional (tumor dose 406 Gy), or bidirectional (crossfired) (2 × 203 Gy). We measured vessel permeability to molecules of 3 sizes (Gd-DOTA, Dotarem®, 0.56 kDa; gadolinium-labeled albumin, ∼74 kDa; gadolinium-labeled IgG, 160 kDa) by daily in vivo magnetic resonance imaging (MRI), from 1 day before to 10 days post-irradiation.
RESULTS
An equivalent tumor dose of bidirectional MRT delivered from two orthogonal directions increased tumor vessel permeability for the smallest molecule tested more effectively than unidirectional MRT. Bidirectional MRT also affected the permeability of normal contralateral vessels to a different extent than unidirectional MRT. Conversely, bidirectional MRT did not modify the permeability of normal or tumor vessels for both larger molecules (74 and 160 kDa).
CONCLUSIONS
High-dose bidirectional (cross-fired) MRT induced a significant increase in tumor vessel permeability for small molecules between the first and the seventh day after irradiation, while permeability of vessels in normal brain tissue remained stable. Such a permeability window could facilitate an efficient and safe delivery of intravenous small molecules (≤0.56 kDa) to tumoral tissues. A permeability window was not achieved by molecules larger than gado-grafted albumin (74 kDa). Vascular permeability for molecules between these two sizes has not been determined.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Anatomy 04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Anatomy > Topographical and Clinical Anatomy |
UniBE Contributor: |
Potez, Marine Therese Charlette, Laissue, Jean, Djonov, Valentin Georgiev, Bouchet, Audrey Michele |
Subjects: |
600 Technology > 610 Medicine & health 500 Science > 570 Life sciences; biology |
ISSN: |
1879-355X |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
21 Feb 2024 11:19 |
Last Modified: |
24 Jul 2024 00:12 |
Publisher DOI: |
10.1016/j.ijrobp.2024.02.007 |
PubMed ID: |
38373658 |
Uncontrolled Keywords: |
Synchrotron microbeam radiation therapy (MRT) blood brain (tumor) barrier brain tumor magnetic resonance imaging (MRI) small and larger contrast agents (0.56 to 160 kDa) vascular permeability window |
BORIS DOI: |
10.48350/193080 |
URI: |
https://boris.unibe.ch/id/eprint/193080 |